| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/27/2007 | US20070224630 Compositions and methods of selective nucleic acid isolation |
| 09/27/2007 | US20070224624 Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto |
| 09/27/2007 | US20070224618 Method for determining protein solubility |
| 09/27/2007 | US20070224610 Method of quantifying hiv-1 rna-dna hydrid and diagnosis kit |
| 09/27/2007 | US20070224589 Protection of Biologically Active Molecules Using Amphiphiles |
| 09/27/2007 | US20070224325 Xylanase |
| 09/27/2007 | US20070224257 Brucellosis dna vaccine |
| 09/27/2007 | US20070224217 Virulence genes of M. marinum and M. tuberculosis |
| 09/27/2007 | US20070224210 Immunostimulatory nucleic acids |
| 09/27/2007 | US20070224208 Ras mutation and compositions and methods related thereto |
| 09/27/2007 | US20070224198 Antithrombotic agents |
| 09/27/2007 | US20070224195 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 09/27/2007 | US20070224193 Methods of increasing lean tissue mass using ob protein compositions |
| 09/27/2007 | US20070224188 humanized anti-CD20 antibodies comprising a human IgG1 Fc region; for treating lymphoma |
| 09/27/2007 | US20070224185 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 09/27/2007 | US20070224183 Pure drug product consisting of collagenase I and collagenase II having the sequence of Clostridium histolyticum collagenase I and collagenase II; possibly Xiaflex (tradename) |
| 09/27/2007 | US20070224176 introducing an oligonucleotide into a donor cell, particularly a stem cell, and contacting the target cell with the donor cell under conditions permitting the donor cell to form a gap junction channel composed of connexin 43 with the target cell, thus donor cell delivers oligonucleotide to target cell |
| 09/27/2007 | US20070224170 Adenovirus/Alphavirus Hybrid Vector for the Effective Administration and Expression of Therapeutic Genes in Tumour Cells |
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | US20070224125 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 09/27/2007 | US20070224124 Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein |
| 09/27/2007 | US20070224123 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/27/2007 | US20070224122 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 09/27/2007 | US20070224121 Connective Tissue Growth Factor-4 |
| 09/27/2007 | US20070224118 Methods for soluble zalpha11 cytokine receptors |
| 09/27/2007 | US20070221563 Nucleic Acid-Adsorbing Porous Membrane for Separating and Purifying Nucleic Acid and Apparatus for Separating and Purifying Nucleic Acid |
| 09/27/2007 | DE102006017760A1 Verfahren zur enzymatischen Herstellung von 2-Hydroxy-2-methylcarbonsäuren Process for the enzymatic preparation of 2-hydroxy-2-methyl carboxylic acids |
| 09/27/2007 | CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | CA2646643A1 Methods for preventing and treating amyloidogenic diseases |
| 09/27/2007 | CA2646583A1 Novel nucleotide sequences encoding nicotiana beta-1,2-xylosyltransferase |
| 09/27/2007 | CA2646508A1 Stabilized polypeptide compositions |
| 09/27/2007 | CA2646476A1 Stress resistant plants |
| 09/27/2007 | CA2646471A1 Novel genes encoding insecticidal proteins |
| 09/27/2007 | CA2645983A1 Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
| 09/27/2007 | CA2645831A1 Anti-tat226 antibodies and immunoconjugates |
| 09/27/2007 | CA2645739A1 Protein purification |
| 09/27/2007 | CA2645120A1 Treatment of cns conditions |
| 09/27/2007 | CA2644669A1 Fad-2 mutants and high oleic plants |
| 09/27/2007 | CA2644663A1 Agonist antibody to human thrombopoietin receptor |
| 09/27/2007 | CA2644347A1 Small internally segmented interfering rna |
| 09/27/2007 | CA2638977A1 D-amino acid selection for soybean |
| 09/27/2007 | CA2638772A1 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 09/27/2007 | CA2638755A1 Methods and compositions for antagonism of rage |
| 09/27/2007 | CA2637137A1 A novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 09/27/2007 | CA2634814A1 Use of apoptosis-specific eif-5a sirna to down regulate expression of proinflammatory cytokines to treat sepsis |
| 09/26/2007 | EP1837407A2 Nucleic acid sequencing by monitoring of uptake of precursors during molecular replication, with molecule dispenser |
| 09/26/2007 | EP1837406A2 Nucleic acid sequencing by Raman monitoring of uptake of precursors during molecular replication |
| 09/26/2007 | EP1837401A1 A fibrinolysin of agkistrodon acutus venom and its usage |
| 09/26/2007 | EP1837400A1 Novel tannase gene and protein thereof |
| 09/26/2007 | EP1837399A1 Anticancer agent |
| 09/26/2007 | EP1837398A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 09/26/2007 | EP1837397A1 FAD-2 mutants and high oleic plants |
| 09/26/2007 | EP1837396A1 Salutaridine reductase and morphine biosynthesis |
| 09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 09/26/2007 | EP1837035A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 09/26/2007 | EP1837017A2 Microparticles for delivery of nucleic acid |
| 09/26/2007 | EP1836907A1 Processed meat product or fish paste product and process for producing the same |
| 09/26/2007 | EP1836319A2 Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification |
| 09/26/2007 | EP1836317A2 Methods and compositions for detecting bacillus anthracis |
| 09/26/2007 | EP1836309A2 Reconstituted human breast tumor model in mouse |
| 09/26/2007 | EP1836308A2 Transplastomic plants free of the selectable marker gene |
| 09/26/2007 | EP1836307A2 Plant stress tolerance from modified ap2 transcription factors |
| 09/26/2007 | EP1836306A2 Compositions comprising promoter sequences and methods of use |
| 09/26/2007 | EP1836305A1 Expression vectors for treating bacterial infections |
| 09/26/2007 | EP1836304A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 09/26/2007 | EP1836303A2 Retrotransposon inhibition in therapy |
| 09/26/2007 | EP1836302A2 Ligation-based rna amplification |
| 09/26/2007 | EP1836301A1 Method for screening and selecting ligands |
| 09/26/2007 | EP1836300A1 Cancer-targeted viral vectors |
| 09/26/2007 | EP1836298A2 COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| 09/26/2007 | EP1836297A2 Phi 15 dna polymerase |
| 09/26/2007 | EP1836294A2 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 09/26/2007 | EP1836226A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 09/26/2007 | EP1836225A1 Kir-binding agents and methods of use thereof |
| 09/26/2007 | EP1836224A1 Bcma polypeptides and uses thereof |
| 09/26/2007 | EP1836223A2 Hemopexin-like structure as polypeptide-scaffold |
| 09/26/2007 | EP1836222A1 Biopolymer including prolamin and methods of making it |
| 09/26/2007 | EP1835983A1 Semi-permeable membrane system for magnetic particle fractions |
| 09/26/2007 | EP1835933A2 Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
| 09/26/2007 | EP1835928A2 Mas related g protein coupled receptors as drug targets |
| 09/26/2007 | EP1756148A4 Insecticidal toxin complex fusion proteins |
| 09/26/2007 | EP1725661A4 Polynucleotides for the detection of escherichia coli o157 |
| 09/26/2007 | EP1709172B1 Method and kit for isolating rna |
| 09/26/2007 | EP1706485B1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS |
| 09/26/2007 | EP1699926A4 Stress tolerant plants and methods thereof |
| 09/26/2007 | EP1653808A4 Neurogenin3 and production of pancreatic islet cells |
| 09/26/2007 | EP1633867A4 Methods of making plants that exhibit enhanced disease resistance |
| 09/26/2007 | EP1620539A4 Transgenic plants with increased glycine-betaine |
| 09/26/2007 | EP1534828A4 Modifying the control of gene expression behavior by the deletion of connectrons and by the design and addition of synthetic connectrons in prokaryotic, archea and eukaryotic genomes |
| 09/26/2007 | EP1495142B1 "doping" in walk-through mutagenesis |
| 09/26/2007 | EP1490768B1 Adaptive behavioural intrusion detection |
| 09/26/2007 | EP1409740B1 Asthma-associated gene |
| 09/26/2007 | EP1391464B1 Anti-cd40 monoclonal antibody |
| 09/26/2007 | EP1356119B1 The preparation of polynucleotide arrays |
| 09/26/2007 | EP1346054B1 Nucleic acids coding for vacuolar invertases, vegetal cells and plants containing said nucleic acids and the use thereof |
| 09/26/2007 | EP1297164B1 Promoters of gene expression in plant caryopses |
| 09/26/2007 | EP1287361B1 Surface for the immobilisation of ligands |
| 09/26/2007 | EP1276860B1 Databases of regulatory sequences; methods of making and using same |
| 09/26/2007 | EP1263928B1 Identification of antigenic peptides by cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 09/26/2007 | EP1224300B9 Heterologous production of polyketides |